Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
PHE and NHS England launch joint £11.5m strategy to wipe out TB in the UK

Public Health England (PHE) and NHS England have today (19 January 2015) announced an £11.5 million investment as part of a collaborative initiative to decrease TB cases and ultimately eliminate TB as a public health problem in England.

Published
19 January 2015
From
Public Health England press release
Recent Ukranian Tuberculosis Outbreak Due to Lack of Medicine

At a press conference convened by the AIDS Healthcare Foundation Ukraine today, a group of patients, experts and activists delivered a strong message that the country is experiencing a preventable tuberculosis (TB) outbreak this year due to the failure of state procurements to obtain essential medications. Activists urged that immediate measures be taken to address the crisis, including distributing needed medical supplies, creating transparent procurement systems and assessing the effectiveness of TB treatment for each patient in accordance to international standards.

Published
15 January 2015
From
AIDS Healthcare Foundation press release
ART during tuberculosis therapy reduces mortality risk for people with HIV

There is a high mortality rate among people living with HIV undergoing treatment for tuberculosis (TB), according to the results of a meta-analysis published in PLOS One.

Published
19 December 2014
By
Michael Carter
Ukraine’s capital is facing an explosive TB epidemic

Kiev may be facing an unprecedented tuberculosis crisis. This is according to Larissa Kanarovskaya, the Head of the Kiev City Union of health workers. On December 1, 2014, at a press conference (a video in Russian can be seen here), she announced that on the average, 100 people die every day in Ukraine’s capital, of which one case is from active tuberculosis.

Published
17 December 2014
From
TB Europe Coalition
Johnson & Johnson announces collaboration between Janssen and USAID to expand access to anti-multidrug-resistant tuberculosis (MDR-TB) compound

Memorandum of Understanding signed to address the global health threat of antibiotic-resistant bacteria.

Published
12 December 2014
From
PR Newswire
Drug-resistant infections could lead to 10 million extra deaths a year – report

The stark figures, published on Thursday, and believed to be the first to quantify the potential impact of antimicrobial resistance (AMR) – drug-resistant infections or superbugs – will be used to make the case to global leaders that urgent action is needed. To put the figures in context there are currently 8.2 million deaths a year from cancer and annual global GDP stands at $70tn to $75tn, with the UK figure around $3tn.

Published
11 December 2014
From
The Guardian
Xpert TB Takes Twice Longer Than Standard TB Test In HIV+ Of Durban

Xpert MTB/RIF testing for pulmonary tuberculosis in a central lab took twice longer than sputum smear microscopy among HIV-positive patients with suspected pulmonary TB in Durban, South Africa. The authors believe Xpert results in “operational delays that limit the test's clinical utility for diagnosing pulmonary TB” in their patients.

Published
09 December 2014
From
International AIDS Society
The Next Big Epidemic: The Wave of Tuberculosis

In the midst of the current widespread Ebola outbreak, we have to stop and think. What is the next epidemic – and are we already facing it? Even though tuberculosis is treatable, it is spreading rapidly, taking the lives of over 1.5 million people each ...

Published
05 December 2014
From
Saporta Report
European HIV response "falling behind" as Eastern European epidemic grows

HIV diagnoses have increased by 80% in the European region since 2004, and three quarters of new HIV diagnoses in the European region are occurring in Eastern

Published
05 December 2014
By
Keith Alcorn
Sanofi: FDA Approves Priftin Tablets To Treat Latent Tuberculosis Infection

French drug maker Sanofi announced Tuesday that Priftin (rifapentine) tablets for the treatment of latent tuberculosis infection has received approval from the U.S. Food and Drug Administration.

Published
02 December 2014
From
RTT News
← First12345...87Next →

Filter by country